Navigation Links
Actavis to Host 2014 Investor Meeting January 31 in New York
Date:1/6/2014

DUBLIN, Jan. 6, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that it will host an Investor Meeting on January 31, 2014 in New York. The meeting will begin at 8:00 a.m. EST and will be webcast simultaneously.

The meeting will be hosted by Actavis' executive leadership team and will provide an overview of executional results in 2013, initiatives to drive long-term growth and an in-depth look at the company following the acquisition of Warner Chilcott plc last year, including the Company's latest financial forecast.  A question-and-answer session will follow the formal presentations.

In-person attendance at the meeting is by invitation only. The webcast will be available live to investors and the media on Actavis' Web site or at the following link: http://www.videonewswire.com/event.asp?id=97019.

A replay of the webcast will be available approximately two hours following the completion of the event on the Company's Web site.

About ActavisActavis plc (NYSE: ACT) is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products.  Actavis has global headquarters in Dublin, Ireland and U.S. administrative headquarters in Parsippany, New Jersey, USA. 

Actavis markets generic, branded generic, legacy brands and Over-the-Counter (OTC) products in more than 60 countries, and operates a global branded specialty pharmaceutical business focused in the Women's Health, Urology, Gastroenterology and Dermatology therapeutic categories.  Actavis also has a portfolio of five biosimilar products in development in Women's Health and Oncology.  Actavis Global Operations has more than 30 manufacturing and distribution facilities around the world, and includes Anda, Inc., a U.S. pharmaceutical product distributor.

For press release and other company information, visit Actavis' Web site at http://www.actavis.com.CONTACTS: Investors:Lisa DeFrancesco (862) 261-7152Media:Charlie Mayr(862) 261-8030David Belian(862) 261-8141(Logo:  http://photos.prnewswire.com/prnh/20130124/NY47381LOGO )


'/>"/>
SOURCE Actavis plc
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
10. Actavis, Inc. to Present at the Cowen & Company 33rd Annual Health Care Conference
11. Actavis, Inc. to Present at the Barclays 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mass. , March 23, 2017 Merrimack ... enrollment of its first patient in a Phase 1 ... antibody-directed nanotherapeutic (ADN) that encapsulates a novel taxane and ... is overexpressed in 50-100% of many major tumor types, ... "The initiation of this study is an ...
(Date:3/23/2017)... , March 23, 2017 Global Colposcope Market ... on the Colposcope in Global market, especially in North ... Asia-Pacific , South America , ... report categorizes the market based on manufacturers, regions, type and application. ... Browse 190 Tables ...
(Date:3/23/2017)... 23, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... that the English version of the Annual report for 2016 ... ... NeuroVive NeuroVive Pharmaceutical AB is a leader in ... development of medicines that preserve mitochondrial integrity and function in ...
Breaking Medicine Technology:
(Date:3/23/2017)... Rey, CA (PRWEB) , ... March 23, 2017 ... ... its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance ... optimizes and accelerates the coding audit process for all medical chart types with ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “Wounded Woman ... “Wounded Woman Be Ye Healed-Passing On A Legacy” is the creation of published author, ... founder of Comfortbearers grief ministry. She has been happily married to her husband, ...
(Date:3/23/2017)... ... 2017 , ... “A Respectful Response To Atheist Manifesto”: theological ... Manifesto” is the creation of published author Richard Hostetter, a former missionary in ... holds graduate degrees from Kent State University and the University of Ghana. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... the publication of “Profiling protein expression in circulating tumor cells using microfluidic western ... the use of the Vortex technology to capture CTCs and a ...
(Date:3/22/2017)... (PRWEB) , ... March 23, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... BioPharma Asia Convention, currently taking place at the Suntec Singapore International Exhibition & ...
Breaking Medicine News(10 mins):